Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Breeshey Roskams-Hieter

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Genome Biology|January 12, 2026
baal-nf identifies motif-disrupting variants that decrease transcription factor binding affinityBreeshey Roskams-Hieter, Øyvind Almelid, Chris P Ponting
Medrxiv : the Preprint Server for Health Sciences|November 19, 2025
Epistatic contributions to human traits via transcription factor mechanismsBreeshey Roskams-Hieter, Olivier Labayle, Kelsey Tetley-Campbell, et al.
Biostatistics (Oxford, England)|September 30, 2025
Semiparametric efficient estimation of small genetic effects in large-scale population cohortsOlivier Labayle, Breeshey Roskams-Hieter, Joshua Slaughter, et al.
Communications Biology|August 29, 2023
Selective enrichment of plasma cell-free messenger RNA in cancer-associated extracellular vesiclesHyun Ji Kim, Matthew J Rames, Florian Goncalves, et al.
NPJ Precision Oncology|April 26, 2022
Plasma cell-free RNA profiling distinguishes cancers from pre-malignant conditions in solid and hematologic malignanciesBreeshey Roskams-Hieter, Hyun Ji Kim, Pavana Anur, et al.
Nature Communications|July 13, 2026
Transcriptomic analysis of tissue-resident memory T cells of the fallopian tube reveals a precursor immune surveillance network for ovarian cancer preventionLuyao Wang, Breeshey Roskams-Hieter, Nosheen Hussain, et al.
Nature Communications|August 9, 2025
Cell free RNA detection of pancreatic cancer in pre diagnostic high risk and symptomatic patientsTravis W Moore, Elias Spiliotopoulos, Rowan L Callahan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2025
Oxford Classic-defined EMT risk stratification of High Grade Serous Ovarian cancer for guiding treatment decisionsLena Rai, Antonella Ravaggi, Eliana Bignotti, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Genome Biology|January 12, 2026
baal-nf identifies motif-disrupting variants that decrease transcription factor binding affinityBreeshey Roskams-Hieter, Øyvind Almelid, Chris P Ponting
Medrxiv : the Preprint Server for Health Sciences|November 19, 2025
Epistatic contributions to human traits via transcription factor mechanismsBreeshey Roskams-Hieter, Olivier Labayle, Kelsey Tetley-Campbell, et al.
Biostatistics (Oxford, England)|September 30, 2025
Semiparametric efficient estimation of small genetic effects in large-scale population cohortsOlivier Labayle, Breeshey Roskams-Hieter, Joshua Slaughter, et al.
Communications Biology|August 29, 2023
Selective enrichment of plasma cell-free messenger RNA in cancer-associated extracellular vesiclesHyun Ji Kim, Matthew J Rames, Florian Goncalves, et al.
NPJ Precision Oncology|April 26, 2022
Plasma cell-free RNA profiling distinguishes cancers from pre-malignant conditions in solid and hematologic malignanciesBreeshey Roskams-Hieter, Hyun Ji Kim, Pavana Anur, et al.
Nature Communications|July 13, 2026
Transcriptomic analysis of tissue-resident memory T cells of the fallopian tube reveals a precursor immune surveillance network for ovarian cancer preventionLuyao Wang, Breeshey Roskams-Hieter, Nosheen Hussain, et al.
Nature Communications|August 9, 2025
Cell free RNA detection of pancreatic cancer in pre diagnostic high risk and symptomatic patientsTravis W Moore, Elias Spiliotopoulos, Rowan L Callahan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2025
Oxford Classic-defined EMT risk stratification of High Grade Serous Ovarian cancer for guiding treatment decisionsLena Rai, Antonella Ravaggi, Eliana Bignotti, et al.
Pageof 1